{
    "2019-04-10": [
        [
            {
                "time": "2023-04-26",
                "original_text": "上海医药(02607.HK)4月26日举行董事会会议，以批准一季度业绩",
                "features": {
                    "keywords": [
                        "上海医药",
                        "董事会会议",
                        "一季度业绩"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-26",
                "original_text": "上海医药(02607.HK)：建议采纳股票期权激励计划",
                "features": {
                    "keywords": [
                        "上海医药",
                        "股票期权",
                        "激励计划"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-26",
                "original_text": "上海医药(02607.HK)控股子公司获药品GMP证书",
                "features": {
                    "keywords": [
                        "上海医药",
                        "控股子公司",
                        "药品GMP证书"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-26",
                "original_text": "带量采购、两票制冲击 医药流通企业寻出路",
                "features": {
                    "keywords": [
                        "带量采购",
                        "两票制",
                        "医药流通企业"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-26",
                "original_text": "近百只影子股攀亲科创板 直接参股的上市公司不到10家",
                "features": {
                    "keywords": [
                        "影子股",
                        "科创板",
                        "直接参股",
                        "上市公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}